Sai Life Sciences Ltd.

Research Sai Life Sciences Ltd. (SAILIFE.NS) on Bullrun: market cap INR 295.21B, P/E 82.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 295.21B; P/E is 82.1.

Peer valuation comparison

Latest P/E is 82.07x versus a Healthcare sector median of 21.74x (277.4% above).

Latest P/E is 82.07x versus a India median of 34.43x (138.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 295.21B82.1n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 INR.

About Sai Life Sciences Ltd.

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Sai Life Sciences Ltd.'s market cap?

Sai Life Sciences Ltd.'s market capitalization is INR 295.21B.

What is Sai Life Sciences Ltd.'s P/E ratio?

Sai Life Sciences Ltd.'s price-to-earnings (P/E) ratio is 82.1.

What does Sai Life Sciences Ltd. do?

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.